technetium 99m HYNIC-E(c(RGDfK))2

Known as: 99mTc-HYNIC-E(c(RGDfK))2 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2017
01220002017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The present study aimed at exploring the patient and imaging characteristics of primary neuroendocrine tumors (NETs) of rare… (More)
Is this relevant?
2012
2012
Peptides are attracting increasing interest in nuclear oncology for targeted tumor diagnosis and therapy. We therefore… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
The use of radiolabeled peptide ligands as diagnostics and therapeutics in nuclear oncology has increased recently. One of the… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
2010
2010
UNLABELLED The mouse double-minute 2 (MDM2) oncogene, amplified or overexpressed in many human cancers, has been suggested to be… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2008
2008
AIM To explore and compare the radiochemical behavior and biological property of anti-sense oligonuc-leotide (ASON) labeled with… (More)
Is this relevant?
2003
2003
UNLABELLED The aim of this study was to compare the imaging abilities of the recently developed somatostatin analog, (99m)Tc… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2000
2000
Indium-111 labelledDTPA-d-Phe1-octreotide (DTPA-OC, OctreoScan) has been introduced into clinical routine for the detection of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?